Atp Clinical Research

Orange, California 92868

8 studies enrolling now · 15 studies all time

What they study most

Anhedonia, Bipolar Depression, Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder, Depression, Depression - Major Depressive Disorder, Depression Disorder, Depression Disorders, Depression in Adults, Depressive Disorder, Major, Major Depressive Disorder

Studies at this site

• A Study of Brenipatide in Adult Participants With Major Depressive Disorder — Recruiting now
• A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1) — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder — Recruiting now
• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder — Recruiting now
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease — Recruiting now
• An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) — Recruiting now
• A Study to Evaluate the Effect of KarXT on Urological Safety — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) — Recruiting now
• An Open-Label Study of Azetukalner in Major Depressive Disorder — Enrolling by invitation
• A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder — Running, not enrolling
• A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure — Stopped early
• Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder — Completed
• Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients — Completed
• A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant — Stopped early
• ANC-501 in the Treatment of Adults With Major Depressive Disorder — Completed